Journal Article10.1152/PHYSREV.2000.80.2.717
Neurotoxins Affecting Neuroexocytosis
TL;DR: The mechanism of action of three groups of presynaptic neurotoxins that interfere directly with the process of neurotransmitter release is reviewed, whereas presynapses acting on ion channels are not dealt with here.
read more
Abstract: Nerve terminals are specific sites of action of a very large number of toxins produced by many different organisms. The mechanism of action of three groups of presynaptic neurotoxins that interfere directly with the process of neurotransmitter release is reviewed, whereas presynaptic neurotoxins acting on ion channels are not dealt with here. These neurotoxins can be grouped in three large families: 1) the clostridial neurotoxins that act inside nerves and block neurotransmitter release via their metalloproteolytic activity directed specifically on SNARE proteins; 2) the snake presynaptic neurotoxins with phospholipase A(2) activity, whose site of action is still undefined and which induce the release of acethylcholine followed by impairment of synaptic functions; and 3) the excitatory latrotoxin-like neurotoxins that induce a massive release of neurotransmitter at peripheral and central synapses. Their modes of binding, sites of action, and biochemical activities are discussed in relation to the symptoms of the diseases they cause. The use of these toxins in cell biology and neuroscience is considered as well as the therapeutic utilization of the botulinum neurotoxins in human diseases characterized by hyperfunction of cholinergic terminals.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
OnabotulinumtoxinA and multiple sclerosis
Brigitte Schurch,Stefano Carda +1 more
TL;DR: Quality of life and patient satisfaction seem not to be affected by the need of intermittent catheterisation, but the risk of urinary infection after the procedure is to be kept in mind, mainly in patients with multiple sclerosis, so that adequate antibiotic prophylaxis is highly recommended.
21
In vitro assays to measure SNARE-mediated vesicle fusion.
TL;DR: Control the lipid and protein composition provides important tools to detect fusion intermediates (e.g., hemifusion), and to elucidate the molecular mechanisms that regulate membrane fusion.
21
•Journal Article
Detection of botulinum toxins: micromechanical and fluorescence-based sensors.
Parpura,Edwin R. Chapman +1 more
TL;DR: A micromechanosensor that relies on the attachment of a bead to the micromachined cantilever through the interactions between SNARE proteins, and an additional sensor based on subcellular redistribution of YFP fluorescence in cells used for cell-based screening of toxin activity.
Bacterial toxins and the immune system: show me the in vivo targets
TL;DR: A large number of bacterial toxins have been shown in vitro to disrupt immune cell functions and whether these toxins have specifically evolved to disrupt the adaptive immune system is unclear.
A search for synthetic peptides that inhibit soluble N-ethylmaleimide sensitive-factor attachment receptor-mediated membrane fusion
Chang H. Jung,Yoosoo Yang,Jun Seob Kim,Jae Il Shin,Yong Su Jin,Jae Y. Shin,Jong H. Lee,Koo Min Chung,Jae S. Hwang,Jung Mi Oh,Yeon-Kyun Shin,Dae-Hyuk Kweon +11 more
TL;DR: The results suggest that the N‐terminal regions of SNARE motifs are excellent targets for the development of drugs to block SNARE‐mediated membrane fusion and neurotransmitter release.
20
References
SNAP receptors implicated in vesicle targeting and fusion
Thomas H. Söllner,Sidney W. Whiteheart,Michael Brunner,Hediye Erdjument-Bromage,Scott J. Geromanos,Paul Tempst,James E. Rothman +6 more
TL;DR: The existence of numerous SNARE-related proteins, each apparently specific for a single kind of vesicles or target membrane, indicates that NSF and SNAPs may be universal components of a vesicle fusion apparatus common to both constitutive and regulated fusion (including neurotransmitter release), in which the SNAREs may help to ensure vesICLE-to-target specificity.
3.4K
SNAREpins: Minimal Machinery for Membrane Fusion
Thomas Weber,Boris V. Zemelman,James A. McNew,Benedikt Westermann,Michael Gmachl,Francesco Parlati,Thomas H. Söllner,James E. Rothman +7 more
TL;DR: Recombinant v- and t- SNARE proteins reconstituted into separate lipid bilayer vesicles assemble into SNAREpins-SNARE complexes linking two membranes, leading to spontaneous fusion of the docked membranes at physiological temperature.
2.5K
Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution
TL;DR: The X-ray crystal structure of a core synaptic fusion complex containing syntaxin-1A, synaptobrevin-II and SNAP-25B reveals a highly twisted and parallel four-helix bundle that differs from the bundles described for the haemagglutinin and HIV/SIV gp41 membrane-fusion proteins.
2.5K
Mechanisms of intracellular protein transport.
TL;DR: In this article, the authors uncovered the general protein apparatus used by all eukaryotes for intracellular transport, including secretion and endocytosis, and for triggered exocytotic of hormones and neurotransmitters.
2.2K
•Journal Article
Mechanisms of intracellular protein transport
TL;DR: The general protein apparatus used by all eukaryotes for intracellular transport, including secretion and endocytosis, and for triggered exocyTosis of hormones and neurotransmitters, is uncovered.
2.2K
Related Papers (5)
Stephen S. Arnon,Robert Schechter,Thomas V. Inglesby,Donald A. Henderson,John G. Bartlett,Michael S. Ascher,Edward M. Eitzen,Anne D. Fine,Jerome Hauer,Marcelle Layton,Scott R. Lillibridge,Michael T. Osterholm,Tara O'Toole,Gerald W. Parker,Trish M. Perl,Philip K. Russell,David L. Swerdlow,Kevin Tonat +17 more